Spire Wealth Management lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 25.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,236 shares of the medical research company’s stock after selling 427 shares during […]
StockNews.com started coverage on shares of Charles River Laboratories International (NYSE:CRL – Free Report) in a report published on Thursday. The firm issued a hold rating on the medical research company’s stock. A number of other analysts also recently weighed in on CRL. TheStreet downgraded shares of Charles River Laboratories International from a b- rating […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) VP William D. Barbo sold 5,763 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $217.24, for a total transaction of $1,251,954.12. Following the sale, the vice president now owns 3,592 […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, August 9th. Analysts expect the company to announce earnings of $2.62 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link. […]
Cambiar Investors LLC boosted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 25.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,087 shares of the medical research company’s stock after buying an additional 8,607 […]